Verseon (LSE: VSN)

Verseon Return vs. S&P

Verseon Company Info

Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.